CARBESIA - CAVALLI NON-DPA

€255.00 (In Stock)

Company:

MSD Animal Health S.r.l.

Publication date:

11/06/2026

Category:

Veterinary Medicinal Product

AIC:

101952024

GTIN:

05017363023459

Pack:

100 ml vial

Indications:

Treatment and prophylaxis of infestations caused by the haemoparasites Babesia caballi and Babesia equi.

Dosage:

a) Treatment of babesiosis (Babesia caballi, Babesia equi): The dose is 2 ml/100 kg b.w., corresponding to 170 mg of Imidocarb base; generally a single treatment is sufficient to eliminate infestation by Babesia caballi, whereas treatment of infestations caused by Babesia equi may require administration of 2 doses 24-72 hours apart depending on the clinical course of the disease.

b) Prophylaxis of babesiosis (Babesia caballi, Babesia equi): The dose is 2 ml/100 kg b.w., corresponding to 170 mg of Imidocarb base; a single administration provides protective cover for a maximum period of 4 weeks.

c) Sterilisation of Babesia infestations Babesia caballi: 2 ml/100 kg b.w. (corresponding to 170 mg of Imidocarb base) twice, 24 hours apart. Infestations Babesia equi: 4 ml/100 kg b.w. (corresponding to 340 mg of Imidocarb base) 4 times at 72-hour intervals. In horses shown to be refractory to sterilisation treatment of Babesia equi infestations, a subsequent sterilisation intervention must not be started before 6 weeks after completion of the ongoing one.

Carbesia must not be administered intravenously. In horses not intended for food production, both the intramuscular and subcutaneous routes may be used in any area of the body, although for reasons of convenience or aesthetics the preferred region for administration is the neck.

Dispensing status:

Non-repeatable prescription

ATCvet Anatomical Group:

QP - 51 - Antiprotozoals

Administration:

Injectable

Species:

Equidae not intended for food production

Active substances:

NameConcentration

imidocarb

85 mg/ml

Withdrawal periods:

Not applicable